These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

966 related articles for article (PubMed ID: 28314701)

  • 21. Erythema multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis: acute ocular manifestations, causes, and management.
    Chang YS; Huang FC; Tseng SH; Hsu CK; Ho CL; Sheu HM
    Cornea; 2007 Feb; 26(2):123-9. PubMed ID: 17251797
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A cross-sectional comparative study on chronic ocular manifestations of Stevens-Johnson syndrome and toxic epidermal necrolysis in Chinese eyes: a 15-year case series.
    Chow LLW; Ng ALK; Chow SSW; Choy BNK; Shih KC; Wong IYH; Chan JCY; Lai JSM
    Int Ophthalmol; 2018 Jun; 38(3):1155-1160. PubMed ID: 28547534
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Complications of Stevens-Johnson syndrome beyond the eye and skin.
    Saeed H; Mantagos IS; Chodosh J
    Burns; 2016 Feb; 42(1):20-27. PubMed ID: 25865527
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Stevens-Johnson syndrome and toxic epidermal necrolysis in a teaching hospital in Lomé, Togo: retrospective study of 89 cases].
    Saka B; Kombaté K; Mouhari-Toure A; Akakpo S; Tchangaï-Walla K; Pitché P
    Med Trop (Mars); 2010 Jun; 70(3):255-8. PubMed ID: 20734593
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recurrence and outcomes of Stevens-Johnson syndrome and toxic epidermal necrolysis in children.
    Finkelstein Y; Soon GS; Acuna P; George M; Pope E; Ito S; Shear NH; Koren G; Shannon MW; Garcia-Bournissen F
    Pediatrics; 2011 Oct; 128(4):723-8. PubMed ID: 21890829
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Study of genital manifestations of Stevens Johnson Syndrome/Toxic Epidermal Necrolysis.
    Gulanikar A; Abrol A; Sagar S
    Indian J Sex Transm Dis AIDS; 2022; 43(1):39-42. PubMed ID: 35846537
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ocular Manifestations of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Children.
    Catt CJ; Hamilton GM; Fish J; Mireskandari K; Ali A
    Am J Ophthalmol; 2016 Jun; 166():68-75. PubMed ID: 27018234
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Management of dysphagia in toxic epidermal necrolysis (TEN) and Stevens-Johnson syndrome (SJS).
    Clayton NA; Kennedy PJ
    Dysphagia; 2007 Jul; 22(3):187-92. PubMed ID: 17287925
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Retrospective Cohort Study of the Management and Outcomes of Children Hospitalized with Stevens-Johnson Syndrome or Toxic Epidermal Necrolysis.
    Antoon JW; Goldman JL; Shah SS; Lee B
    J Allergy Clin Immunol Pract; 2019 Jan; 7(1):244-250.e1. PubMed ID: 29859332
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Stevens-Johnson syndrome and toxic epidermal necrolysis: a review of the clinical experience of a University Hospital (1989-2008)].
    Ferrándiz-Pulido C; García-Fernández D; Gómez-Morell P; Palao R; García-Patos V
    Med Clin (Barc); 2011 May; 136(13):583-7. PubMed ID: 21414644
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Drug-induced Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), and SJS-TEN overlap: a multicentric retrospective study.
    Barvaliya M; Sanmukhani J; Patel T; Paliwal N; Shah H; Tripathi C
    J Postgrad Med; 2011; 57(2):115-9. PubMed ID: 21654132
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk factors for the development of ocular complications of Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Gueudry J; Roujeau JC; Binaghi M; Soubrane G; Muraine M
    Arch Dermatol; 2009 Feb; 145(2):157-62. PubMed ID: 19221260
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nine years of a single referral center management of Stevens-Johnson syndrome and toxic epidermal necrolysis (Lyell's syndrome).
    Monteiro D; Egipto P; Barbosa J; Horta R; Amarante J; Silva P; Silva A
    Cutan Ocul Toxicol; 2017 Jun; 36(2):163-168. PubMed ID: 27487073
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Incidence of toxic epidermal necrolysis and Stevens-Johnson Syndrome in an HIV cohort: an observational, retrospective case series study.
    Mittmann N; Knowles SR; Koo M; Shear NH; Rachlis A; Rourke SB
    Am J Clin Dermatol; 2012 Feb; 13(1):49-54. PubMed ID: 22145749
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The nationwide epidemiological survey of Stevens-Johnson syndrome and toxic epidermal necrolysis in Japan, 2016-2018.
    Sunaga Y; Kurosawa M; Ochiai H; Watanabe H; Sueki H; Azukizawa H; Asada H; Watanabe Y; Yamaguchi Y; Aihara M; Mizukawa Y; Ohyama M; Hama N; Abe R; Hashizume H; Nakajima S; Nomura T; Kabashima K; Tohyama M; Takahashi H; Mieno H; Ueta M; Sotozono C; Niihara H; Morita E; Kokaze A
    J Dermatol Sci; 2020 Dec; 100(3):175-182. PubMed ID: 33046331
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical manifestations and outcomes in 17 cases of Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Wong KC; Kennedy PJ; Lee S
    Australas J Dermatol; 1999 Aug; 40(3):131-4. PubMed ID: 10439522
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Stevens-Johnson syndrome and toxic epidermal necrolysis in childhood-onset systemic lupus erythematosus patients: a multicenter study.
    Sakamoto AP; Silva CA; Saad-Magalhães C; Alencar AN; Pereira RMR; Kozu K; Barbosa CMPL; Terreri MT
    Acta Reumatol Port; 2017; 42(3):250-255. PubMed ID: 28375199
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The natural history of Stevens Johnson syndrome: patterns of chronic ocular disease and the role of systemic immunosuppressive therapy.
    De Rojas MV; Dart JK; Saw VP
    Br J Ophthalmol; 2007 Aug; 91(8):1048-53. PubMed ID: 17314145
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term Sequelae of Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis.
    Yang CW; Cho YT; Chen KL; Chen YC; Song HL; Chu CY
    Acta Derm Venereol; 2016 May; 96(4):525-9. PubMed ID: 26582440
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lamotrigine Emerging as a Driver of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: An 8-Year Retrospective Study.
    Glahn JZ; Almeida MN; Kochen A; Noel O; Stogner V; Hsia HC; Savetamal A
    Burns; 2024 Nov; 50(8):2114-2123. PubMed ID: 39127578
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 49.